Chemed Corporation $CHE Shares Purchased by Van Berkom & Associates Inc.

Van Berkom & Associates Inc. raised its position in Chemed Corporation (NYSE:CHEFree Report) by 33.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 170,813 shares of the company’s stock after acquiring an additional 42,390 shares during the quarter. Chemed makes up approximately 2.2% of Van Berkom & Associates Inc.’s portfolio, making the stock its 21st biggest position. Van Berkom & Associates Inc. owned 1.17% of Chemed worth $76,480,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of CHE. Creekmur Asset Management LLC acquired a new position in shares of Chemed in the second quarter valued at approximately $28,000. First Horizon Corp purchased a new position in Chemed in the 3rd quarter valued at approximately $31,000. Pilgrim Partners Asia Pte Ltd purchased a new position in Chemed in the 3rd quarter valued at approximately $45,000. Parkside Financial Bank & Trust grew its stake in shares of Chemed by 86.3% in the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after acquiring an additional 44 shares in the last quarter. Finally, HM Payson & Co. increased its position in shares of Chemed by 35.5% during the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after acquiring an additional 27 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the completion of the sale, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.29% of the stock is owned by corporate insiders.

Chemed Stock Down 0.7%

CHE stock opened at $432.35 on Wednesday. The business has a 50 day moving average price of $436.35 and a 200 day moving average price of $441.98. The stock has a market cap of $6.12 billion, a price-to-earnings ratio of 22.86, a PEG ratio of 2.12 and a beta of 0.44. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date was Monday, November 17th. Chemed’s dividend payout ratio (DPR) is currently 12.69%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CHE shares. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Royal Bank Of Canada reduced their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $555.50.

View Our Latest Stock Report on Chemed

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Recommended Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.